John Lupiano
Internal Medicine · New York, NYNPI 1881634954
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 38.6% of the total. Reporting peaked in 2019 at $5,163 and has fallen 97.6% since, to $125 in 2024. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 73 payments — averaging $115.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$711
- Otsuka America Pharmaceutical, Inc.$576
- UCB, Inc.$497
- Gilead$491
- Avanir Pharmaceuticals, Inc.$480
- plus $2K from 14 others
What the payments were for
- Food & beverage$8,430100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $3,253 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 6 | $711 |
| Otsuka America Pharmaceutical, Inc. | 5 | $576 |
| UCB, Inc. | 4 | $497 |
| Gilead | 4 | $491 |
| Avanir Pharmaceuticals, Inc. | 5 | $480 |
| Johnson & Johnson | 4 | $332 |
| Eisai Inc. | 2 | $245 |
| Abbott | 2 | $245 |
| MDD US Operations, LLC | 2 | $232 |
| Bristol Myers Squibb | 2 | $231 |
| Medtronic | 1 | $205 |
| Astellas Pharma US Inc | 1 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Acorda Therapeutics, Inc | 1 | $122 |
| Sunovion Pharmaceuticals Inc. | 1 | $116 |
| Lilly USA, LLC | 1 | $100 |
| Amryt Pharma Holdings Ltd | 1 | $95 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,435 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in New York
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
- Terry PlasseNew York$883K
- Krisczar BungayNew York$554K
- Eytan SteinNew York$496K
- Larry NeumanNew York$457K
- Wuhua JingNew York$338K
- Harvey SchneienNew York$334K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.